Moreover, HE4 has been described as a driver of immune failure in ovarian tumors by compromising cytotoxic CD8+ T cells through upregulation of self-produced dual-specificity phosphatase 6 (DUSP6) [85]. Here, CD8A is linked to ovarian neoplasm.